• About Us
  • Contact
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Editorial Charter
  • Corrections Policy
  • Sitemap
Freelanews
Advertisement
  • Home
  • News
    • Crime
  • Business
  • Brands
  • Banking
  • Opinion
  • Interview
  • Entertainment
  • Podcast
    • Àtẹ́lẹwọ́
  • Sports
  • Events
No Result
View All Result
  • Home
  • News
    • Crime
  • Business
  • Brands
  • Banking
  • Opinion
  • Interview
  • Entertainment
  • Podcast
    • Àtẹ́lẹwọ́
  • Sports
  • Events
No Result
View All Result
Freelanews
No Result
View All Result
Home News General

‘Covid toes’ New coronavirus side effect identified in new research

Freelanews by Freelanews
October 7, 2021
in General
0 0
0
COVID 19 PS 1
thenacre-campaign

According to a new research, a new side effect that could impact those recuperating from coronavirus has been discovered.

The immune system’s response to Covid-19 could result in ‘Covid toes.’

But what exactly are Covid toes, what are the symptoms, and what causes them?

Covid toes causes chilblain-like irritation and redness on the hands and feet, and the condition can linger for months.

It causes swollen or discolored toes and fingers and usually emerges within a week to four weeks of being infected with Covid.

Perfect-Aesthetic-social-1

It can affect people of any age, but it is more common in children and teenagers.

Some people have little pain, while others have a rash that is exceedingly itchy and painful, with sharp blisters and swelling.

The damaged skin, which primarily affects the toes but can also impact the fingers, can appear red or purple, and some people develop uncomfortable raised bumps or rough skin.

There could be pus, and some patients could be unwell for weeks, if not months.

What is the difference between chilblains and Covid toes?

Chilblains are itchy, tiny red patches that occur after being exposed to the cold. Chilblains often emerge a few hours after being exposed to the cold and affect your fingers and toes, but they can also affect your face and legs.

They normally go away on their own in two to three weeks, but if they don’t, you should consult a doctor.

What is the cause of Covid toes?

adron lemon friday

A new study – published in the British Journal of Dermatology – has found that Covid toes could be a side effect of the immune system’s response to coronavirus.

Researchers behind the study examined 50 participants with Covid toes and 13 with similar chilblains lesions that arose before the pandemic.

The study found that one mechanism behind both types of the condition involved the body generating an immune response with high levels of certain autoantibodies, which mistakenly target and react with a person’s own cells and tissues as well as the invading virus.

Researchers also found an overlap with type I interferon, which is a key protein in the antiviral response.

Cells lining blood vessels which supply the affected areas also appeared to play a critical role in the development of Covid toes and chilblains.

Senior author of the study, Dr Charles Cassius, said the research provided a deeper understanding of the condition.

He said: “The epidemiology and clinical features of chilblain-like lesions have been extensively studied and published, however, little is known about the pathophysiology involved.

freelanews
Freelanews

Freelanews is the editorial byline of Freelanews.com, used for staff reports, news updates, press releases, and collaborative stories produced by the Freelanews Editorial Team.

Also read

  • Akinwunmi challenges Nigerian Ad agencies to prove their value in AI era
  • Osun NLC begins 3-day strike over withheld LG funds

Related Posts

Cobhams Asuquo
General

‘We go win’ Cobhams Asuquo signs for COVID-19

by Freelanews
April 4, 2020
cannabis plant 1100x625 1 scaled
General

‘Nigeria has many consumers’ South Africa approves first legal cannabis pharmacy

by Freelanews
April 26, 2022
APC LOGO
General

‘Waivers’ Concessions will be granted to defectors from rival parties, APC claims

by Rtn. Victor Ojelabi
December 21, 2020
Asari Dokubo Military Challenge
General

Asari Dokubo military challenge: defence HQ dares him to enter battlefield

by Quadri Olaitan
October 10, 2024
Elon Musk’s daughter leaves US
General

Elon Musk’s estranged Daughter plans to leave US after Trump’s election victory

by Quadri Olaitan
November 8, 2024

Leave a Reply Cancel reply

Tiktok Community

You're not logged into Tiktok, please login here
UBA bank ad UBA bank ad UBA bank ad

Recent News

Osoba

Osoba admits being godfather, says he won’t interfere in Abiodun’s government

November 10, 2026
Canada makes

Canada makes rural immigration programme permanent

November 10, 2026
photo 2026 11 10 06 14 32

Odunaike faults exclusion of 13 candidates from Lagos debate

November 10, 2026
photo 2026 11 10 06 14 24

Elumelu urges African businesses to give women more leadership roles

November 10, 2026
  • Trending
  • Comments
  • Latest
N250k signature

Abiodun vs Amosun: N250k signature plot deepens Ogun political crisis ahead Tinubu visit

April 3, 2026
Omoge Saida

Omoge Saida sparks Nigerian social media over leaked video

October 28, 2025
#image_title

17 mobile money operator companies licensed by CBN in Nigeria

March 22, 2023
Australia

Ifeoma playfully reacts as Paul Okoye receives recognition in Australia

April 24, 2026
amoke

‘Meals by Amoke’ We serve traditional dishes in a modern way, Bukoye Fasola reveals

19
Image 2024 03 26 at 120645 AM jpeg

Charles Inojie, Ali Nuhu call on communities to #MakeWeHalla against domestic violence

11
Meran Primary Health Centre Lagos father Meran hospital

Lagos father shares heartbreaking experience at Meran Primary Health Centre (Photos)

4
fls2

‘Disarticulated system’ Gov’t confused about Nigerian education, expert laments

3
Osoba

Osoba admits being godfather, says he won’t interfere in Abiodun’s government

November 10, 2026
Canada makes

Canada makes rural immigration programme permanent

November 10, 2026
photo 2026 11 10 06 14 32

Odunaike faults exclusion of 13 candidates from Lagos debate

November 10, 2026
photo 2026 11 10 06 14 24

Elumelu urges African businesses to give women more leadership roles

November 10, 2026
ADVERTISEMENT
November 2026
SMTWTFS
1234567
891011121314
15161718192021
22232425262728
2930 
« Oct    
Freelanews

Freelanews is a Nigerian digital news platform that delivers timely, credible, and engaging stories across politics, business, entertainment, lifestyle, and the creative industry, with a strong focus on promoting innovation, integrity, and inclusivity in storytelling.

Today’s Popular

  • #image_title

    17 mobile money operator companies licensed by CBN in Nigeria

    0 shares
    Share 0 Tweet 0
  • ‘Breaking News’ Babatunde Omidina, Baba Suwe, is dead

    0 shares
    Share 0 Tweet 0
  • Ifeoma playfully reacts as Paul Okoye receives recognition in Australia

    0 shares
    Share 0 Tweet 0
  • NYSC sagamu camp faces criticism over poor living conditions

    0 shares
    Share 0 Tweet 0

Just Published!

Osoba

Osoba admits being godfather, says he won’t interfere in Abiodun’s government

November 10, 2026
Canada makes

Canada makes rural immigration programme permanent

November 10, 2026
photo 2026 11 10 06 14 32

Odunaike faults exclusion of 13 candidates from Lagos debate

November 10, 2026
photo 2026 11 10 06 14 24

Elumelu urges African businesses to give women more leadership roles

November 10, 2026
photo 2026 11 10 06 14 19

Lagos Theatre Festival returns with ‘The Masks We Wear’ theme

November 10, 2026
No Result
View All Result
  • About Us
  • Contact
  • Cookie Policy
  • Editorial Charter
  • Corrections Policy
  • Advertisement

© 2026 Freelanews | by Iretura.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • News
    • Crime
  • Business
  • Brands
  • Banking
  • Opinion
  • Interview
  • Entertainment
  • Podcast
    • Àtẹ́lẹwọ́
  • Sports
  • Events

© 2026 Freelanews | by Iretura.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.